Showing results (211-220 of 305) with videos related to
Sort By:
Pageof 31
TH Open : Companion Journal to Thrombosis and Haemostasis|May 29, 2020
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI TrialAlok A Khorana, Mairéad G McNamara, Ajay K Kakkar, et al.JAMA|January 18, 1985
Chronic supraventricular tachycardia. A curable cause of congestive cardiomyopathyP C Gillette, R T Smith, A Garson, et al.Journal of Clinical Medicine|October 9, 2019
Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical PracticeAngela Lamarca, Hamish Clouston, Jorge Barriuso, et al.Plos One|April 3, 2019
A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolomeShahil Amin, Jodi Rattner, Mohammad Reza Keramati, et al.JHEP Reports : Innovation in Hepatology|March 26, 2026
Advanced: post-hoc analysis of the ABC-01, -02 and -03 clinical trialsAngela Lamarca, Paul Ross, Harpreet S Wasan, et al.Cell Reports|January 23, 2025
Multi-level encoding of reward, effort, and choice across the frontal cortex and basal ganglia during cost-benefit decision-makingOliver Härmson, Isaac Grennan, Brook Perry, et al.Journal of Clinical Medicine|September 9, 2020
Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract CancersAngela Lamarca, Zainul Kapacee, Michael Breeze, et al.Current Oncology Reports|June 29, 2017
Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced CholangiocarcinomaPavan Najran, Angela Lamarca, Damian Mullan, et al.Neuroendocrinology|October 23, 2019
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine NeoplasmsKok Haw Jonathan Lim, Hussain Raja, Paolo D'Arienzo, et al.Journal of Neuro-Oncology|January 29, 2014
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progressionMairéad G McNamara, Zarnie Lwin, Haiyan Jiang, et al.Pageof 31